Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants
Akshaya Srikanth Bhagavathula, Benjamin Woolf, Jamal Rahmani, Kota Vidyasagar, Wubshet Tesfaye
Dive into the research topics of 'Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants'. Together they form a unique fingerprint.